Biotech

All Articles

Gene publisher Volume giving up 131 workers

.Merely times after gene editor Volume Biosciences announced unrevealed operational slices, a cleare...

Repare lays off 25% of personnel as biotech stops preclinical R&ampD

.Repare Therapeutics is giving up an one-fourth of its own staff as the oncology biotech lessen its ...

J &amp J files for FDA confirmation of $6.5 B autoimmune drug

.Johnson &amp Johnson has actually taken an additional measure towards recognizing a yield on its $6...

Gain's phase 1 succeed paves means to verify Parkinson's drug's worth

.Gain Rehabs has actually established its own sights on showing the efficiency of its Parkinson's il...

Actinogen records brand new period 2 information to restore clinical depression medicine

.Actinogen Medical's chances-- as well as stock cost-- have actually rebounded a little coming from ...

Pfizer and Flagship incorporate Quotient to multibillion-dollar equation

.Front Runner Pioneering as well as Pfizer have incorporated Quotient right into their 10-program co...

Bayer pens $547M pact to drive limits of noncoding RNA

.Bayer execs were interested to anxiety to Fierce this summer that the German pharma titan's hunger ...

UK introduces plans to introduce 18 brand new clinical test centers

.Among a yearslong scientific trial decrease in the U.K., a brand new public-private partnership has...

UPDATE: Genentech telegrams 93 cutbacks in California after discussing plans to shutter cancer cells immunology analysis unit

.Complying with the announcement of a huge layoff round in April and a primary rebuilding effort rev...

Neurocrine's KarXT opponent hits in stage 2-- yet merely at low dosage

.Neurocrine Biosciences has actually achieved its hoped-for account in a period 2 schizophrenia tria...